Scott J. Saccomano, PhD, GNP-BC, RN, Lucille R. Ferrara, EdD, RN, MBA, FNP-BC
Although accreditation for this CE/CME activity has expired, and the posttest is no longer available, you can still read the full article.
Expires June 30, 2014 – Although 15- to 24-year-olds account for the greatest incidence of infectious mononucleosis (IM), antibodies to the Epstein-Barr virus, the causative organism, may be present in 95% of the population. Learn to distinguish between IM and other illnesses with similar presentations—and to watch for the potentially severe complications of IM.
References
CE/CME No: CR-1306
PROGRAM OVERVIEW Earn credit by reading this article and successfully completing the posttest. Successful completion is defined as a cumulative score of at least 70% correct.
EDUCATIONAL OBJECTIVES • Discuss the pathophysiology of the Epstein-Barr virus (EBV) and its manifestation in infectious mononucleosis (IM). • Name specific factors that distinguish IM from each of several conditions to be considered in the differential diagnosis. • Describe the use of heterophile antibody testing and EBV serology testing to confirm a diagnosis of IM. • Explain supportive management, activity restrictions, potential complications, and essentials of patient education for IM.
FACULTY Scott J. Saccomano is an Assistant Professor in the Family Nurse Practitioner Program, Department of Nursing, at Herbert H. Lehman College in Bronx, New York. Lucille R. Ferrara is an Assistant Professor and Director of the Family Nurse Practitioner Program in the Department of Graduate Studies at Pace University, College of Health Professions, Lienhard School of Nursing, in Pleasantville, New York.
The authors have no significant financial relationships to disclose.
ACCREDITATION STATEMENT
This program has been reviewed and is approved for a maximum of 1.0 hour of American Academy of Physician Assistants (AAPA) Category I CME credit by the Physician Assistant Review Panel; and by the Nurse Practitioner Association New York State (The NPA) for 1.0 contact hour. Approval is valid for one year from the issue date of June2013.
